Hide Board Information

Show Board Information

Recursion Pharmaceuticals Inc. RXRX

Board Mod: LateToLearn

Asst Mods:

Last Post: 01/09/2024 7:00:17 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) Stock Message Board

1. RXRX Company Profile

    

2. RXRX Time & Sales

    

3. RXRX Recent News

    

4. RXRX Filings

    

5. RXRX Financials

    

6. RXRX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	This was likely in response to continued efforts	LateToLearn	01/09/2024 7:00:17 PM
5	It happened again, "Cathie Wood continues to load	LateToLearn	01/09/2024 6:55:00 PM
4	Nice move for December. Nvidia brings attention	LateToLearn	12/19/2023 3:48:35 PM
3	Nvidia partnership to 4x their computer	LateToLearn	11/28/2023 1:56:26 PM
2	Anything you can share about this company.	LateToLearn	11/19/2023 10:49:43 AM
1	$RXRX 78% v80,1M c12.08 f192,359M H14.99	znewcar1	07/12/2023 10:56:53 PM

Recent Articles

• LG's Vision to Lead as a Global HVAC Solution Innovator
• WEKA Launches NeuralMesh Axon for Enhanced AI Performance
• Broadridge's Innovative Solutions for EU Instant Payments
• Clarifai Launches AI Runners: Revolutionizing AI Deployment
• Future Growth of Hydrogen Technology TIC Market Explored
• Samsung's Chip Profit Decline and Upcoming Innovations Ahead
• Discover the Rich Heritage of the Steppe Silk Road Journey
• Economists Alarmed by Trump’s Tariff Moves Against Japan and Korea
• Exciting Launch of TRUMP Memecoin on Tron Blockchain Ahead
• Corporate Restructuring Challenges Looming Over Europe
• Petco's Summer Celebration: Fun for Pets and Owners
• Diginex Proposes Strategic Eight-for-One Stock Split Plan
• Innovative Partnership Between NIO's Firefly and HERE Technologies
• Japan's Prime Minister Shigeru Ishiba Critiques Tariff Imposition
• Nassim Taleb Expresses Concerns for Elon Musk Amid Controversies
• Investigation of Centene Corporation: Key Facts for Investors
• Edelson Lechtzin Investigates Potential Issues with PetMed Express
• XDC Token's Recent Surge: What Investors Need to Know
• WuXi AppTec's Strategic Moves in Share Repurchase and Talent Acquisition
• Perseus Mining Announces Upcoming Investor Webinar Event
• TrinaTracker and DNV Enhance Wind Testing for Vanguard 1P
• Celltrion USA Launches New Denosumab Biosimilars to Patients
• Unlocking Bitcoin Mining Potential: The Future is AI and Green Energy
• Black Hawk Acquisition Updates Proxy Statement for Clarity
• Fluence Secures Contract for Major Battery Storage Project
• Market Reaction: Cryptocurrencies Show Resilience Amid Tariffs
• Fluence Partners with AMPYR for Major Energy Storage Project
• Historic Milestone for SCG Cell Therapy's Innovative HBV Treatment
• Meta Welcomes Apple AI Executive With a Generous Deal
• A Look at Advantech's Innovative Edge AI Solutions
• The Keg Royalties Income Fund Advances Strategic Transaction
• Frugal Lessons from the CEO's Mother on Coffee Choices
• Market Movements: Analyzing Top Stocks and Their Trends
• Legal Opportunities for Rocket Pharmaceuticals Investors
• Pandora Jewelry's Share Buyback Program: A Comprehensive Overview
• Apple Inc. Securities Class Action: What Investors Should Know
• Discover Incredible Deals at Newegg's 11th Annual FantasTech Sale
• Centene Corporation Faces Legal Investigation Amid Stock Discrepancies
• BellRing Brands Faces Legal Scrutiny Over Shareholder Rights
• Investigation Updates on Amylyx Pharmaceuticals: What Holders Should Know
• Investigation of FMC Corporation: Implications for Shareholders
• Investors Alert: Class Action Lawsuits File Updates on Companies
• DMC Global Inc. Faces Investigation Over Alleged Misleading Practices
• Investor Alerts on Class Actions for Hims & Hers, Sarepta, and Petco
• Updates on Legal Actions Involving key Companies in Tech and Health
• Investigation into Key Players: Apple and Others Face Scrutiny
• Legal Actions Against Fortrea, Reckitt, UroGen, and Red Cat
• Fosun International Achieves Remarkable Sustainability Recognition
• China Airlines Sets to Elevate Travel at New York's Terminal One
• Investigation of TechTarget, Inc. Securities: Know Your Rights